Literature DB >> 7687301

Identification and mapping of the gene encoding the glycoprotein complex gp82-gp105 of human herpesvirus 6 and mapping of the neutralizing epitope recognized by monoclonal antibodies.

B Pfeiffer1, Z N Berneman, F Neipel, C K Chang, S Tirwatnapong, B Chandran.   

Abstract

Monoclonal antibodies (MAbs) 2D4, 2D6, and 13D6 against human herpesvirus 6 (HHV-6) variant A strain GS recognized virion envelope glycoprotein complex gp82-gp105 and neutralized the infectivity of HHV-6 variant A group isolates. A 624-bp genomic fragment (82G) was identified from an HHV-6 strain GS genomic library constructed in the lambda gt11 expression system by immunoscreening with MAb 2D6. Rabbit antibodies against the fusion protein expressed from the genomic insert recognized glycoprotein complex gp82-gp105 from HHV-6-infected cells, thus confirming that the genomic fragment is a portion of the gene(s) that encodes gp82-gp105. This genomic insert hybridized specifically with viral DNAs from HHV-6 variant A strains GS and U1101 under high-stringency conditions but hybridized with HHV-6 variant B strain Z-29 DNA only under low-stringency conditions. DNA sequence analysis of the insert revealed a 167-amino-acid single open reading frame with an open 5' end and a stop codon at the 3' end. Hybridization studies with HHV-6A strain U1102 DNA localized the gp82-gp105-encoding gene to the unique long region near the direct repeat at the right end of the genome. To locate the neutralizing epitope(s) recognized by the MAbs, a series of deletions from the 3' end of the gene were constructed with exonuclease III, and fusion proteins from deletion constructs were tested for reactivity with MAbs in a Western immunoblot assay. Sequencing of deletion constructs at the reactive-nonreactive transition point localized the epitope recognized by the three neutralizing MAbs within or near a repeat amino acid sequence (NIYFNIY) of the putative protein. This repeat sequence region is surrounded on either side by two potential N-glycosylation sites and three cysteine residues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7687301      PMCID: PMC237846     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Polymorphism of human herpesvirus 6 DNA from five Japanese patients with exanthem subitum.

Authors:  H Kikuta; H Lu; S Matsumoto; S F Josephs; R C Gallo
Journal:  J Infect Dis       Date:  1989-09       Impact factor: 5.226

2.  Human herpesvirus-6 infection (exanthem subitum) without rash.

Authors:  S Suga; T Yoshikawa; Y Asano; T Yazaki; S Hirata
Journal:  Pediatrics       Date:  1989-06       Impact factor: 7.124

3.  Variation in restriction map of MHV-6 genome.

Authors:  R F Jarrett; A Gallagher; S Gledhill; M D Jones; I Teo; B E Griffin
Journal:  Lancet       Date:  1989-02-25       Impact factor: 79.321

4.  Identification of proteins specific for human herpesvirus 6-infected human T cells.

Authors:  N Balachandran; R E Amelse; W W Zhou; C K Chang
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

5.  Molecular studies of HHV-6.

Authors:  S F Josephs; D V Ablashi; S Z Salahuddin; B Kramarsky; B R Franza; P Pellett; A Buchbinder; S Memon; F Wong-Staal; R C Gallo
Journal:  J Virol Methods       Date:  1988-09       Impact factor: 2.014

6.  Use of TrpE/Gag fusion proteins to characterize immunoreactive domains on the human immunodeficiency virus type 1 core protein.

Authors:  M G Windheuser; G E Tegtmeier; C Wood
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

7.  Variations in the replication and antigenic properties of human herpesvirus 6 strains.

Authors:  L S Wyatt; N Balachandran; N Frenkel
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

8.  The genome of human herpesvirus 6: maps of unit-length and concatemeric genomes for nine restriction endonucleases.

Authors:  M E Martin; B J Thomson; R W Honess; M A Craxton; U A Gompels; M Y Liu; E Littler; J R Arrand; I Teo; M D Jones
Journal:  J Gen Virol       Date:  1991-01       Impact factor: 3.891

9.  Antigenic relationships among human herpesvirus-6 isolates.

Authors:  B Chandran; S Tirawatnapong; B Pfeiffer; D V Ablashi
Journal:  J Med Virol       Date:  1992-08       Impact factor: 2.327

10.  Characterization of a new strain of HHV-6 (HHV-6SF) recovered from the saliva of an HIV-infected individual.

Authors:  J A Levy; F Ferro; E T Lennette; L Oshiro; L Poulin
Journal:  Virology       Date:  1990-09       Impact factor: 3.616

View more
  13 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Analysis of a neutralizing antibody for human herpesvirus 6B reveals a role for glycoprotein Q1 in viral entry.

Authors:  Akiko Kawabata; Hiroko Oyaizu; Takahiro Maeki; Huamin Tang; Koichi Yamanishi; Yasuko Mori
Journal:  J Virol       Date:  2011-09-28       Impact factor: 5.103

3.  Identification and analysis of a novel heparin-binding glycoprotein encoded by human herpesvirus 7.

Authors:  D Skrincosky; P Hocknell; L Whetter; P Secchiero; B Chandran; S Dewhurst
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

Review 4.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Human herpesvirus 6 variant A glycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46.

Authors:  Yasuko Mori; Xuwei Yang; Pilailuk Akkapaiboon; Toshiomi Okuno; Koichi Yamanishi
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

6.  Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B.

Authors:  Y Isegawa; T Mukai; K Nakano; M Kagawa; J Chen; Y Mori; T Sunagawa; K Kawanishi; J Sashihara; A Hata; P Zou; H Kosuge; K Yamanishi
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A.

Authors:  G Dominguez; T R Dambaugh; F R Stamey; S Dewhurst; N Inoue; P E Pellett
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

Review 8.  Immune response to HHV-6 and implications for immunotherapy.

Authors:  Aniuska Becerra; Laura Gibson; Lawrence J Stern; J Mauricio Calvo-Calle
Journal:  Curr Opin Virol       Date:  2014-10-27       Impact factor: 7.090

Review 9.  Classification of HHV-6A and HHV-6B as distinct viruses.

Authors:  Dharam Ablashi; Henri Agut; Roberto Alvarez-Lafuente; Duncan A Clark; Stephen Dewhurst; Dario DiLuca; Louis Flamand; Niza Frenkel; Robert Gallo; Ursula A Gompels; Per Höllsberg; Steven Jacobson; Mario Luppi; Paolo Lusso; Mauro Malnati; Peter Medveczky; Yasuko Mori; Philip E Pellett; Joshua C Pritchett; Koichi Yamanishi; Tetsushi Yoshikawa
Journal:  Arch Virol       Date:  2013-11-06       Impact factor: 2.574

10.  The human herpesvirus 6 U100 gene product is the third component of the gH-gL glycoprotein complex on the viral envelope.

Authors:  Yasuko Mori; Pilailuk Akkapaiboon; Xuwei Yang; Koichi Yamanishi
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.